St Jude Medical IncNYSE
Historical Stock Data
|52 Week High|
|52 Week Low|
Medtronic Focused on Improving Efficacy of Micra in Fiscal 2018
According to Medtronic (MDT), ~85% of the patients in the US who use pacemakers opt for a dual-chambered device. In fiscal 1Q18, Medtronic reported robust demand for its single-chamber pacemaker, Micra.
A Brief Recap of the Abbott–Alere Deal Developments
Three months after announcing a $5.8 billion deal in which Abbott Laboratories (ABT) would buy Alere (ALR), Alere rejected Abbott's $50 million offer to end the deal. On December 7, Abbott sued Alere to terminate the deal.